Diabetes is Not Significantly Associated with Decreased First-Line Tuberculosis Drug Exposure

被引：0
|
作者：
Sturdy, Ann [1 ]
Romano, Federico [2 ]
Kipper, Karin [3 ]
Barrett, Jessica [1 ]
Whittington, Ashley [4 ]
Kon, Onn Min [1 ]
Oliver, Nick [1 ]
Pasca, Oscar Della
Cooke, Graham
机构：
[1] Imperial Coll London, Fac Med, London, England
[2] Univ Coll London UCL, Sch Pharm, London, England
[3] Epilepsy Soc, Analyt Chem Dept, London, England
[4] Northwick Pk Hosp & Clin Res Ctr, Dept Infect Dis, HARROW, England
来源：
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES | 2025年 / 152卷
关键词：
D O I：
10.1016/j.ijid.2024.107549
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：43 / 44
页数：2
相关论文
共 50 条
  • [21] Current Prospects for the Fluoroquinolones as First-Line Tuberculosis Therapy
    Takiff, Howard
    Guerrero, Elba
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (12) : 5421 - 5429
  • [22] Management of adverse reactions to first-line tuberculosis antibiotics
    Nagarajan, Sowmya
    Whitaker, Paul
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 18 (04) : 333 - 341
  • [23] Prevalence and genetic basis of first-line drug resistance of Mycobacterium tuberculosis in Ca Mau, Vietnam
    Callum, Jack
    Nguyen, Phuong T. B.
    Martinez, Elena
    Nguyen, Van-Anh T.
    Garden, Frances
    Nguyen, Nhung, V
    Thu-Anh Nguyen
    Nguyen, Hoa B.
    Nguyen, Son, V
    Luu, Khanh B.
    Ho, Jennifer
    Linh, Nguyen N.
    Britton, Warwick J.
    Sintchenko, Vitali
    Fox, Greg J.
    Marks, Guy B.
    ERJ OPEN RESEARCH, 2022, 8 (04)
  • [24] A systematic review and meta-analysis of first-line tuberculosis drug concentrations and treatment outcomes
    Perumal, R.
    Naidoo, K.
    Naidoo, A.
    Ramachandran, G.
    Requena-Mendez, A.
    Sekaggya-Wiltshire, C.
    Mpagama, S. G.
    Matteelli, A.
    Fehr, J.
    Heysell, S. K.
    Padayatchi, N.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2020, 24 (01) : 48 - +
  • [25] Recommendations Concerning the First-Line Treatment of Children with Tuberculosis
    Nicola Principi
    Luisa Galli
    Laura Lancella
    Marina Tadolini
    Giovanni Battista Migliori
    Alberto Villani
    Susanna Esposito
    Pediatric Drugs, 2016, 18 : 13 - 23
  • [26] Re-think first-line tuberculosis treatment
    van Ingen, Jakko
    Anthony, Richard M.
    EUROPEAN RESPIRATORY JOURNAL, 2013, 41 (02) : 488 - 489
  • [27] Pharmacokinetics of First-Line Tuberculosis Drugs in Tanzanian Patients
    Tostmann, Alma
    Mtabho, Charles M.
    Semvua, Hadija H.
    van den Boogaard, Jossy
    Kibiki, Gibson S.
    Boeree, Martin J.
    Aarnoutse, Rob E.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (07) : 3208 - 3213
  • [28] THERAPEUTIC DRUG LEVELS OF FIRST-LINE TUBERCULOSIS MEDICATIONS AMONG CHILDREN FROM RURAL TANZANIA
    Justine, Museveni
    Yeconia, Anita
    Ingi, Nicodemu
    Augustino, Domitila
    Gratz, Jean
    Mduma, Estomih
    Mfinanga, Sayoki
    Peloquin, Charles
    Heysell, Scott
    Houpt, Eric
    Thomas, Tania A.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 97 (05): : 581 - 581
  • [29] First-Line Anti-Tubercular Drug Resistance of Mycobacterium tuberculosis in IRAN: A Systematic Review
    Pourakbari, Babak
    Mamishi, Setareh
    Mohammadzadeh, Mona
    Mahmoudi, Shima
    FRONTIERS IN MICROBIOLOGY, 2016, 7
  • [30] The Influence of Adverse Drug Reactions on First-line Anti-tuberculosis Chemotherapy in the Elderly Patients
    Jeong, Jeong Ihm
    Jung, Bock Hyun
    Kim, Mi Hye
    Lim, Jae Min
    Ha, Dong Cheon
    Cho, Sung-Won
    Rhui, Dae Sik
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2009, 67 (04) : 325 - 330
12345